211 related articles for article (PubMed ID: 16552612)
1. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.
de Silva R; Lashley T; Strand C; Shiarli AM; Shi J; Tian J; Bailey KL; Davies P; Bigio EH; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; MacKenzie J; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Holton J; Lees A; Revesz T; Mann DM
Acta Neuropathol; 2006 Apr; 111(4):329-40. PubMed ID: 16552612
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
[TBL] [Abstract][Full Text] [Related]
3. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
[TBL] [Abstract][Full Text] [Related]
4. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
6. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
9. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
10. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.
Shiarli AM; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio EH; Ghetti B; Murrell JR; Delisle MB; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; Mackenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):374-87. PubMed ID: 16866983
[TBL] [Abstract][Full Text] [Related]
11. MAPT S305I mutation: implications for argyrophilic grain disease.
Kovacs GG; Pittman A; Revesz T; Luk C; Lees A; Kiss E; Tariska P; Laszlo L; Molnár K; Molnar MJ; Tolnay M; de Silva R
Acta Neuropathol; 2008 Jul; 116(1):103-18. PubMed ID: 18066559
[TBL] [Abstract][Full Text] [Related]
12. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
13. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.
Mott RT; Dickson DW; Trojanowski JQ; Zhukareva V; Lee VM; Forman M; Van Deerlin V; Ervin JF; Wang DS; Schmechel DE; Hulette CM
J Neuropathol Exp Neurol; 2005 May; 64(5):420-8. PubMed ID: 15892300
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia.
Iseki E; Yamamoto R; Murayama N; Minegishi M; Togo T; Katsuse O; Kosaka K; Akiyama H; Tsuchiya K; de Silva R; Andrew L; Arai H
Neurosci Lett; 2006 Sep; 405(1-2):29-33. PubMed ID: 16859829
[TBL] [Abstract][Full Text] [Related]
16. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
Korn L; Speicher AM; Schroeter CB; Gola L; Kaehne T; Engler A; Disse P; Fernández-Orth J; Csatári J; Naumann M; Seebohm G; Meuth SG; Schöler HR; Wiendl H; Kovac S; Pawlowski M
Redox Biol; 2023 Feb; 59():102597. PubMed ID: 36599286
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
[TBL] [Abstract][Full Text] [Related]
19. Frontotemporal lobar degeneration--tau as a pied piper?
Tolnay M; Probst A
Neurogenetics; 2002 Oct; 4(2):63-75. PubMed ID: 12481984
[TBL] [Abstract][Full Text] [Related]
20. Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation.
Setó-Salvia N; Esteras N; de Silva R; de Pablo-Fernandez E; Arber C; Toomey CE; Polke JM; Morris HR; Rohrer JD; Abramov AY; Patani R; Wray S; Warner TT
J Cell Mol Med; 2022 Feb; 26(4):1327-1331. PubMed ID: 34951131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]